David E. Gloriam
David E. Gloriam


2012: Diploma in Research Management, Copenhagen Business School (CBS)
2006: Ph.D. in Medicine, Uppsala University (UU, see ranking), Sweden
2003: M.Sc. in Pharmaceutical Sciences, UU

2013-: Head of GPCRdb – community resource with 2,500 users/month (gpcrdb.org)
2011-: Group Leader and Associate Professor (gloriamgroup.org), Department of Drug Design and Pharmacology (DDP), University of Copenhagen (UCPH, ranking)
2008-11: Postdoc, DDP
2007-08: Postdoc, GlaxoSmithKline, Harlow, UK
2006-08: Postdoc, EMBL-European Bioinformatics Institute, Hinxton, UK (2nd year 25%)

Awards & honors
2018: Novo Nordisk Foundation Hallas-Møller Ascending Investigator (10M DKK)

2014: ERC Starting Grant (1.5M EUR)
2014: Lundbeck Foundation Fellow (10M DKK)
2013: 1st place in the international GPCR Dock competition (best 5-HT1B receptor model)
2005: First-authored the most downloaded article of the year in BBA - General Subjects

Recipient (main appl.) of 40 M DKK from external foundations and councils
Currently: European Research Commission, Danish Council for Independent Research, Novo Nordisk Foundation, Lundbeck Foundation and Olle Engkvist Foundation.

Selected scientific and academic activities
2016-: Editor of Scientific Reports (Nature Publishing Group)
2014-: Corresponding member, Intl. Union of Pharmacology Nomenclature Committee
2013- 17: Management committee member of the European Research Network ‘GLISTEN
2012-: Evaluated 5 application for foundations and councils, incl. ERC, NWO, FWO,
2007-: Invited speaker at 18 international meetings.
2006-: Organiser of (total/internat.): Meetings/conf. (3/2), GPCRdb meetings (7/7) and Workshops (7/5)
2006-: Reviewer for 19 international journals, incl. Nature

Publications and bibliometrics
See selected or all recent publications
H-index: 27, Citations: 2,497 (Scopus, see current stats)
Peer-reviewed Articles: 62 whereof 35 (56%) in the last 5 years
Authorships; First: 7, Last: 24, Senior modeller: 34
Other: Book chapter: 2, Popular scientific: 2, Proceedings: 2, Patent: 1

See group members and previous members

ID: 5953796